Delivery Order SPE2DR25D1053-SPE2DR26FT163
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure with an ultimate completion date of October 14, 2025. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. The contract was competitively awarded without set-aside designation and carries a completion date of October 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and military healthcare systems through its...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 24, 2025, with an ultimate completion date of October 16, 2025. This is a firm fixed price, non-set-aside delivery order performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $18,496.02 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on August 14, 2025, with completion targeted for September 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, to be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside contract with a completion date of September 25, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of September 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 12, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at...
- The Defense Logistics Agency awarded a $24,661.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on September 18, 2025, with an ultimate completion date of October 9, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively procured...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT163Delivery Order
The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on October 21, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts primarily with the Defense Logistics Agency. The company's federal procurement history demonstrates consistent capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through competitively awarded contracts. The DLA Troop Support Medical IDC serves as the primary vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 10/21/25 |